Upgrade to SI Premium - Free Trial

Replimune (REPL)

15.04 -0.25 (1.64%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/29/26)

Latest Headlines

Replimune Group (REPL) PT Raised to $21 at JPMorgan August 26, 2026 8:49 AM - StreetInsider Form 4 Replimune Group, Inc. For: Aug 20 Filed by: Astley-Sparke Philip August 24, 2026 7:49 PM - SEC Filing Form 4 Replimune Group, Inc. For: Aug 17 Filed by: Hill Emily Luisa August 19, 2026 6:42 PM - SEC Filing Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) August 19, 2026 4:01 PM - Globe NewsWire Form S-3ASR Replimune Group, Inc. August 14, 2026 4:53 PM - SEC Filing Form 10-Q Replimune Group, Inc. For: Jun 30 August 14, 2026 4:13 PM - SEC Filing Form SCHEDULE 13G/A Replimune Group, Inc. Filed by: Ridgeback Capital Investments L.P. August 14, 2026 4:02 PM - SEC Filing Form 8-K Replimune Group, Inc. For: Aug 14 August 14, 2026 8:11 AM - SEC Filing Replimune Reports Fiscal First Quarter 2027 Financial Results and Provides Corporate Update August 14, 2026 8:00 AM - Globe NewsWire Form 4 Replimune Group, Inc. For: Aug 10 Filed by: Patel Sushil August 12, 2026 5:08 PM - SEC Filing Form 4 Replimune Group, Inc. For: Aug 10 Filed by: Hill Emily Luisa August 12, 2026 5:07 PM - SEC Filing Form 4 Replimune Group, Inc. For: Aug 10 Filed by: Xynos Konstantinos August 12, 2026 5:05 PM - SEC Filing Form 4 Replimune Group, Inc. For: Aug 10 Filed by: Schwendenman Andrew August 12, 2026 5:04 PM - SEC Filing Replimune Group (REPL) Reiterated at Overweight by Cantor Fitzgerald August 12, 2026 7:37 AM - StreetInsider Form SCHEDULE 13D/A Replimune Group, Inc. Filed by: BAKER BROS. ADVISORS LP August 11, 2026 5:51 PM - SEC Filing Form 4 Replimune Group, Inc. For: Aug 11 Filed by: BAKER JULIAN August 11, 2026 5:46 PM - SEC Filing Form 8-K/A Replimune Group, Inc. For: Aug 09 August 11, 2026 6:03 AM - SEC Filing Form SCHEDULE 13G Replimune Group, Inc. Filed by: GOLDMAN SACHS GROUP INC August 10, 2026 8:34 PM - SEC Filing Replimune prices $150M stock offering at $12.06 per share August 10, 2026 8:01 AM - StreetInsider Replimune Announces Pricing of $150 Million Underwritten Offering August 10, 2026 8:00 AM - Globe NewsWire Form 8-K Replimune Group, Inc. For: Aug 09 August 10, 2026 7:50 AM - SEC Filing Form 424B5 Replimune Group, Inc. August 10, 2026 7:39 AM - SEC Filing Form SCHEDULE 13G Replimune Group, Inc. Filed by: STATE STREET CORP August 7, 2026 10:51 AM - SEC Filing Replimune Group (REPL) PT Raised to $20 at JPMorgan August 7, 2026 9:09 AM - StreetInsider Replimune Group (REPL) PT Raised to $20 at BMO Capital August 7, 2026 8:10 AM - StreetInsider Wedbush Upgrades Replimune Group (REPL) to Outperform August 7, 2026 6:21 AM - StreetInsider Form 8-K Replimune Group, Inc. For: Aug 06 August 7, 2026 6:05 AM - SEC Filing Replimune (REPL) call put ratio 1 call to 5.8 puts with a focus on August 7 weekly 9 puts and August 14 weekly 2 puts August 7, 2026 4:47 AM - StreetInsider Form SCHEDULE 13G/A Replimune Group, Inc. Filed by: MONTANOVA CAPITAL, LLC August 6, 2026 5:48 PM - SEC Filing FDA grants accelerated approval to Replimune's Tudriqev for melanoma August 6, 2026 4:00 PM - StreetInsider Replimune Announces FDA Accelerated Approval of TUDRIQEVTM in Combination with Nivolumab for Unresectable Advanced Cutaneous Melanoma After Progression on an anti-PD-1 Based Regimen August 6, 2026 4:00 PM - Globe NewsWire FDA approves Replimune melanoma therapy in combo with nivolumab August 6, 2026 3:59 PM - StreetInsider Leerink Upgrades Replimune Group (REPL) to Outperform August 4, 2026 3:43 AM - StreetInsider Piper Sandler Upgrades Replimune Group (REPL) to Overweight July 31, 2026 8:53 AM - StreetInsider Wedbush Upgrades Replimune Group (REPL) to Outperform July 31, 2026 6:47 AM - StreetInsider Form 8-K Replimune Group, Inc. For: Jul 30 July 31, 2026 6:05 AM - SEC Filing Cantor Fitzgerald Upgrades Replimune Group (REPL) to Overweight July 31, 2026 3:54 AM - StreetInsider FDA advisory panel votes 10-3 in favor of Replimune's melanoma drug July 30, 2026 6:15 PM - StreetInsider Replimune Announces Favorable Outcome of FDA's Cellular, Tissue, and Gene Therapies Advisory Committee Meeting for RP1 in Advanced Melanoma July 30, 2026 6:15 PM - Globe NewsWire Form 8-K Replimune Group, Inc. For: Jul 30 July 30, 2026 8:06 AM - SEC Filing Form EFFECT Replimune Group, Inc. July 30, 2026 6:05 AM - SEC Filing Replimune (REPL) call put ratio 1 call to 3.7 puts as share price down 9% July 29, 2026 10:44 AM - StreetInsider Form DEFA14A Replimune Group, Inc. July 29, 2026 6:02 AM - SEC Filing Form DEF 14A Replimune Group, Inc. For: Sep 15 July 29, 2026 6:02 AM - SEC Filing Form ARS Replimune Group, Inc. For: Mar 31 July 29, 2026 6:02 AM - SEC Filing Replimune stock tumbles 20% after FDA raises efficacy concerns July 28, 2026 7:40 AM - StreetInsider Replimune (REPL) Weakness Tied to FDA Briefing Documents, Shares -18% July 28, 2026 7:30 AM - StreetInsider Replimune (REPL) files for 25.1M share offering by selling stockholders July 24, 2026 5:01 PM - StreetInsider Form S-3/A Replimune Group, Inc. July 24, 2026 4:58 PM - SEC Filing Replimune (REPL) call put ratio 1 call to 1 put amid wide price movement July 22, 2026 3:57 AM - StreetInsider Form PRE 14A Replimune Group, Inc. For: Sep 15 July 13, 2026 5:20 PM - SEC Filing Replimune (REPL) call put ratio 1 call to 1.3 puts with a focus on August options July 7, 2026 11:08 AM - StreetInsider BMO Capital Upgrades Replimune Group (REPL) to Outperform June 30, 2026 4:04 AM - StreetInsider Form S-8 Replimune Group, Inc. June 29, 2026 9:18 AM - SEC Filing Form 10-K Replimune Group, Inc. For: Mar 31 June 29, 2026 8:13 AM - SEC Filing Form 8-K Replimune Group, Inc. For: Jun 29 June 29, 2026 8:11 AM - SEC Filing Replimune Reports Fiscal Fourth Quarter and Year End 2026 Financial Results and Provides Corporate Update June 29, 2026 8:00 AM - Globe NewsWire Replimune (REPL) call put ratio 1.6 calls to 1 put June 29, 2026 5:56 AM - StreetInsider JPMorgan Upgrades Replimune Group (REPL) to Overweight June 26, 2026 12:23 PM - StreetInsider Increasing unusual put volume: AS WEN REPL BHC BTG IGV HWM CHYM BURL CIA June 26, 2026 10:32 AM - StreetInsider Form 8-K Replimune Group, Inc. For: Jun 26 June 26, 2026 8:14 AM - SEC Filing FDA accepts Replimune RP1 BLA resubmission for advanced melanoma June 26, 2026 8:01 AM - StreetInsider Replimune Announces FDA Acceptance of RP1 Biologics License Application Resubmission for Advanced Melanoma June 26, 2026 8:00 AM - Globe NewsWire Full Article List